Completed PHASE3 INTERVENTIONAL 2-arm NCT02810275

Folinic Acid: Supplementation and Therapy (FAST)

Effect of Folic Acid on Homocysteine Levels and Flow-mediated Dilation in HIV and HIV-HCV Coinfected Patients: a Randomized Controlled Trial

Sponsor: Hospital de Clinicas de Porto Alegre

Conditions HCV Coinfection HIV Infection

Interventions Folinic Acid Placebo

Updated 5 times since 2017 Last updated: Nov 29, 2016 Started: Oct 31, 2012 Primary completion: Jul 31, 2013 Completion: Sep 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on HCV Coinfection and HIV Infection, this trial is completed. The trial is conducted by Hospital de Clinicas de Porto Alegre and has accumulated 5 data snapshots since 2012. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital de Clinicas de Porto Alegre
Universidade Federal de Santa Maria

Data source: Hospital de Clinicas de Porto Alegre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.